{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:27:34Z","timestamp":1789003654886,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    <jats:bold>Introduction:<\/jats:bold>\n                    A dysregulated inflammatory response, known as \u201ccytokine storm\u201d, plays an important role in the pathophysiology of coronavirus 2019 disease (COVID-19). Identifying patients with a dysregulated inflammatory response and at high risk for severe respiratory failure, organ dysfunction, and death is clinically relevant, as they could benefit from the specific therapies, such as cytokine removal by hemoadsorption. This study aimed to evaluate cytokine hemoadsorption as rescue therapy in critically ill patients with SARS-CoV-2 pneumonia, severe respiratory failure refractory to prone positioning, and hypercytokinemia.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    In this single center, observational and retrospective study, critically ill patients with SARS-CoV-2 pneumonia, severe acute respiratory failure, and hypercytokinemia were analyzed. All the patients underwent cytokine hemoadsorption using CytoSorb\n                    <jats:sup>\u00ae<\/jats:sup>\n                    (Cytosorbents Europe, Berlin, Germany). The indication for treatment was acute respiratory failure, inadequate clinical response to the prone position, and hypercytokinemia.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Among a total of 343 patients who were admitted to the intensive care unit (ICU) due to SARS-CoV-2 infection between March 3, 2020 and June 22, 2020, six patients received rescue therapy with cytokine hemoadsorption. All the patients needed invasive mechanical ventilation and prone positioning. A significant difference was found in the pre- and post-treatment D-dimer (17,868 mcg\/ml [4,196\u201345,287] vs. 4,488 mcg\/ml [3,166\u201317,076],\n                    <jats:italic>p<\/jats:italic>\n                    = 0.046), C-reactive protein (12.9 mg\/dl [10.6] vs. 3.5 mg\/dl [2.8],\n                    <jats:italic>p<\/jats:italic>\n                    = 0.028), ferritin (1,539 mcg\/L [764\u201327,414] vs. 1,197 ng\/ml [524\u20133,857],\n                    <jats:italic>p<\/jats:italic>\n                    = 0.04) and interleukin-6 (17,367 pg\/ml [4,539\u201322,532] vs. 2,403 pg\/ml [917\u20133,724],\n                    <jats:italic>p<\/jats:italic>\n                    = 0.043) levels. No significant differences in the pre- and post-treatment interleukin-10 levels (22.3 pg\/ml [19.2\u2013191] vs. 5.6 pg\/ml [5.2\u201336.6],\n                    <jats:italic>p<\/jats:italic>\n                    = 0.068) were observed. Improvements in oxygenation (prehemoadsorption PaO\n                    <jats:sub>2<\/jats:sub>\n                    \/FIO\n                    <jats:sub>2<\/jats:sub>\n                    ratio 103 [18.4] vs. posthemoadsorption PaO\n                    <jats:sub>2<\/jats:sub>\n                    \/FIO\n                    <jats:sub>2<\/jats:sub>\n                    ratio 222 [20.9],\n                    <jats:italic>p<\/jats:italic>\n                    = 0.029) and in the organ dysfunction (prehemoadsorption SOFA score 9 [4.75] vs. posthemoadsorption SOFA score 7.7 [5.4],\n                    <jats:italic>p<\/jats:italic>\n                    = 0.046) were observed. ICU and in-hospital mortality was 33.7%.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    In this case series, critically ill patients with COVID-19 with severe acute respiratory failure refractory to prone positioning and hypercytokinemia who received adjuvant treatment with cytokine hemoadsorption showed a significant reduction in IL-6 plasma levels and other inflammatory biomarkers. Improvements in oxygenation and SOFA score were also observed.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2021.779038","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T23:49:23Z","timestamp":1641772163000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia"],"prefix":"10.3389","volume":"8","author":[{"given":"Juan Carlos","family":"Ruiz-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Chiscano-Cam\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolf","family":"Ruiz-Sanmartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Palmada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Paola Plata-Menchaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Franco-Jarava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"P\u00e9rez-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Hern\u00e1ndez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00134-020-05967-x","article-title":"Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists","volume":"46","author":"Bouadma","year":"2020","journal-title":"Intensive Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J Heart Lung Transplant."},{"key":"B3","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/17476348.2020.1778470","article-title":"Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2","volume":"14","author":"Robba","year":"2020","journal-title":"Expert Rev Respir Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2020.17052","article-title":"Cytokine levels in critically Ill patients with COVID-19 and other conditions","volume":"324","author":"Kox","year":"2020","journal-title":"JAMA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S2213-2600(21)00218-6","article-title":"The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity","volume":"9","author":"Osuchowski","year":"2021","journal-title":"Lancet Respir Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"593223","DOI":"10.3389\/fphys.2021.593223","article-title":"Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies","volume":"12","author":"Lopes-Pacheco","year":"2021","journal-title":"Front Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J Clin Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/jth.14844","article-title":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19","volume":"18","author":"Dolhnikoff","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell Mol Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1001\/jama.2020.3633","article-title":"Care for critically Ill patients with COVID-19","volume":"323","author":"Murthy","year":"2020","journal-title":"JAMA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"Across speciality collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S2213-2600(20)30226-5","article-title":"Immunomodulation in COVID-19","volume":"8","author":"Ingraham","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000499510","article-title":"oXiris\u00ae Use in septic shock: experience of two French Centres","volume":"47","author":"Schwindenhammer","year":"2019","journal-title":"Blood Purif."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/art.22018","article-title":"European Forum on antiphospholipid antibodies. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients","volume":"54","author":"Bucciarelli","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B17","doi-asserted-by":"publisher","first-page":"577442","DOI":"10.3389\/fimmu.2020.577442","article-title":"Immunomodulation for severe COVID-19 pneumonia: the state of the art","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"A severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"ARDS Definition Task","year":"2012","journal-title":"JAMA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","article-title":"clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract."},{"key":"B22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection","volume":"136","author":"Al-Samkari","year":"2020","journal-title":"Blood."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1097\/CM9.0000000000000819","volume":"133","year":"2020","journal-title":"Chin Med J"},{"key":"B25","first-page":"2020","article-title":"Managing patients in dialysis and with kidney transplant infected with Covid-19","volume":"37","author":"Alberici","year":"2020","journal-title":"G Ital Nefrol"},{"key":"B26","unstructured":"GU\u00cdAS NACIONALES DE ATENCI\u00d3N DE PACIENTES ADULTOS COVID-19 VERSION 2.0."},{"key":"B27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.22265\/acnef.7.Supl.2.473","article-title":"Consenso colombiano de expertos sobre recomendaciones informadas en la evidencia para la prevenci\u00f3n, el diagn\u00f3stico y el manejo de la lesi\u00f3n renal aguda por SARS-CoV-2\/COVID-19","volume":"7","author":"Gonz\u00e1lez","year":"2020","journal-title":"Rev Colomb Nefrol."},{"key":"B28","volume-title":"CytoSorb","year":"2020"},{"key":"B29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.hrtlng.2020.09.007","article-title":"Cytosorb filter: an adjunct for survival in the COVID-19 patient in cytokine storm? A case report","volume":"50","author":"Rizvi","year":"2021","journal-title":"Heart Lung."},{"key":"B30","doi-asserted-by":"publisher","first-page":"969","DOI":"10.26502\/acmcr.96550286","article-title":"Sequential use of hemoadsorption using cytosorb and biosky filter-technology in A COVID-19 patient suffering from severe ARDS","volume":"4","author":"Mezger","year":"2020","journal-title":"Arch Clin Med Case Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1159\/000509738","article-title":"The combined use of tocilizumab and hemoadsorption in a patient with SARS-COV-2-19-associated pneumonia: a case report","volume":"144","author":"Berlot","year":"2020","journal-title":"Nephron."},{"key":"B32","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1159\/000511725","article-title":"Hemoperfusion with CytoSorb as adjuvant therapy in critically Ill patients with SARS-CoV2 pneumonia","volume":"50","author":"Rampino","year":"2021","journal-title":"Blood Purif."},{"key":"B33","doi-asserted-by":"publisher","first-page":"106477","DOI":"10.1016\/j.rmed.2021.106477","article-title":"Extracorporeal cytokine hemadsorption in severe COVID-19 respiratory failure","volume":"185","author":"Damiani","year":"2021","journal-title":"Respir Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/aor.14024","article-title":"Blood purification with CytoSorb in critically ill COVID-19 patients: a case series of 26 patients","volume":"45","author":"Nassiri","year":"2021","journal-title":"Artif Organs."},{"key":"B35","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1177\/03913988211023782","article-title":"Continuous hemadsorption with cytokine adsorber for severe COVID-19: a case series of 15 patients","volume":"44","author":"Paisey","year":"2021","journal-title":"Int J Artif Organs."},{"key":"B36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s13054-020-03322-6","article-title":"Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study","volume":"24","author":"Villa","year":"2020","journal-title":"Crit Care."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","article-title":"Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes\u201d","volume":"8","author":"Leisman","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S2213-2600(21)00177-6","article-title":"Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial","volume":"9","author":"Supady","year":"2021","journal-title":"Lancet Respir Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1001\/archinte.167.15.1655","article-title":"GenIMS Investigators. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study","volume":"167","author":"Kellum","year":"2007","journal-title":"Arch Intern Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.779038\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T23:49:30Z","timestamp":1641772170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.779038\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":39,"alternative-id":["10.3389\/fmed.2021.779038"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.779038","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-575692\/v1","asserted-by":"object"}]},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"article-number":"779038"}}